Cargando…

Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions

In preparation for an α-particle therapy trial using 1–7 MBq of (224)Ra, the feasibility of tomographic SPECT/CT imaging was of interest. The nuclide decays in 6 steps to stable (208)Pb, with (212)Pb as the principle photon-emitting nuclide. (212)Bi and (208)Tl emit high-energy photons up to 2,615 k...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikalsen, Lars Tore Gyland, Kvassheim, Monika, Stokke, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315694/
https://www.ncbi.nlm.nih.gov/pubmed/37268424
http://dx.doi.org/10.2967/jnumed.122.264455
_version_ 1785067551805407232
author Mikalsen, Lars Tore Gyland
Kvassheim, Monika
Stokke, Caroline
author_facet Mikalsen, Lars Tore Gyland
Kvassheim, Monika
Stokke, Caroline
author_sort Mikalsen, Lars Tore Gyland
collection PubMed
description In preparation for an α-particle therapy trial using 1–7 MBq of (224)Ra, the feasibility of tomographic SPECT/CT imaging was of interest. The nuclide decays in 6 steps to stable (208)Pb, with (212)Pb as the principle photon-emitting nuclide. (212)Bi and (208)Tl emit high-energy photons up to 2,615 keV. A phantom study was conducted to determine the optimal acquisition and reconstruction protocol. Methods: The spheres of a body phantom were filled with a (224)Ra-RaCl(2) solution, and the background compartment was filled with water. Images were acquired on a SPECT/CT system. In addition, 30-min scans were acquired for 80- and 240-keV emissions, using triple-energy windows, with both medium-energy and high-energy collimators. Images were acquired at 90–95 and 29–30 kBq/mL, plus an explorative 3-min acquisition at 20 kBq/mL (using only the optimal protocol). Reconstructions were performed with attenuation correction only, attenuation plus scatter correction, 3 levels of postfiltering, and 24 levels of iterative updates. Acquisitions and reconstructions were compared using the maximum value and signal-to-scatter peak ratio for each sphere. Monte Carlo simulations were performed to examine the contributions of key emissions. Results: Secondary photons of the 2,615-keV (208)Tl emission produced in the collimators make up most of the acquired energy spectrum, as revealed by Monte Carlo simulations, with only a small fraction (3%–6%) of photons in each window providing useful information for imaging. Still, decent image quality is possible at 30 kBq/mL, and nuclide concentrations are imageable down to approximately 2–5 kBq/mL. The overall best results were obtained with the 240-keV window, medium-energy collimator, attenuation and scatter correction, 30 iterations and 2 subsets, and a 12-mm gaussian postprocessing filter. However, all combinations of the applied collimators and energy windows were capable of producing adequate results, even though some failed to reconstruct the 2 smallest spheres. Conclusion: SPECT/CT imaging of (224)Ra in equilibrium with daughters is possible, with sufficient image quality to provide clinical utility for the current trial of intraperitoneally administrated activity. A systematic scheme for optimization was designed to select acquisition and reconstruction settings.
format Online
Article
Text
id pubmed-10315694
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Society of Nuclear Medicine
record_format MEDLINE/PubMed
spelling pubmed-103156942023-07-04 Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions Mikalsen, Lars Tore Gyland Kvassheim, Monika Stokke, Caroline J Nucl Med Clinical Investigation In preparation for an α-particle therapy trial using 1–7 MBq of (224)Ra, the feasibility of tomographic SPECT/CT imaging was of interest. The nuclide decays in 6 steps to stable (208)Pb, with (212)Pb as the principle photon-emitting nuclide. (212)Bi and (208)Tl emit high-energy photons up to 2,615 keV. A phantom study was conducted to determine the optimal acquisition and reconstruction protocol. Methods: The spheres of a body phantom were filled with a (224)Ra-RaCl(2) solution, and the background compartment was filled with water. Images were acquired on a SPECT/CT system. In addition, 30-min scans were acquired for 80- and 240-keV emissions, using triple-energy windows, with both medium-energy and high-energy collimators. Images were acquired at 90–95 and 29–30 kBq/mL, plus an explorative 3-min acquisition at 20 kBq/mL (using only the optimal protocol). Reconstructions were performed with attenuation correction only, attenuation plus scatter correction, 3 levels of postfiltering, and 24 levels of iterative updates. Acquisitions and reconstructions were compared using the maximum value and signal-to-scatter peak ratio for each sphere. Monte Carlo simulations were performed to examine the contributions of key emissions. Results: Secondary photons of the 2,615-keV (208)Tl emission produced in the collimators make up most of the acquired energy spectrum, as revealed by Monte Carlo simulations, with only a small fraction (3%–6%) of photons in each window providing useful information for imaging. Still, decent image quality is possible at 30 kBq/mL, and nuclide concentrations are imageable down to approximately 2–5 kBq/mL. The overall best results were obtained with the 240-keV window, medium-energy collimator, attenuation and scatter correction, 30 iterations and 2 subsets, and a 12-mm gaussian postprocessing filter. However, all combinations of the applied collimators and energy windows were capable of producing adequate results, even though some failed to reconstruct the 2 smallest spheres. Conclusion: SPECT/CT imaging of (224)Ra in equilibrium with daughters is possible, with sufficient image quality to provide clinical utility for the current trial of intraperitoneally administrated activity. A systematic scheme for optimization was designed to select acquisition and reconstruction settings. Society of Nuclear Medicine 2023-07 /pmc/articles/PMC10315694/ /pubmed/37268424 http://dx.doi.org/10.2967/jnumed.122.264455 Text en © 2023 by the Society of Nuclear Medicine and Molecular Imaging. https://creativecommons.org/licenses/by/4.0/Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
spellingShingle Clinical Investigation
Mikalsen, Lars Tore Gyland
Kvassheim, Monika
Stokke, Caroline
Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
title Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
title_full Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
title_fullStr Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
title_full_unstemmed Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
title_short Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
title_sort optimized spect imaging of (224)ra α-particle therapy by (212)pb photon emissions
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315694/
https://www.ncbi.nlm.nih.gov/pubmed/37268424
http://dx.doi.org/10.2967/jnumed.122.264455
work_keys_str_mv AT mikalsenlarstoregyland optimizedspectimagingof224raaparticletherapyby212pbphotonemissions
AT kvassheimmonika optimizedspectimagingof224raaparticletherapyby212pbphotonemissions
AT stokkecaroline optimizedspectimagingof224raaparticletherapyby212pbphotonemissions